Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

1.

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.

Chappell AS, Bradley LA, Wiltse C, Detke MJ, D'Souza DN, Spaeth M.

Int J Gen Med. 2008 Nov 30;1:91-102.

PMID:
20428412
[PubMed]
Free PMC Article
2.

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.

Chappell AS, Littlejohn G, Kajdasz DK, Scheinberg M, D'Souza DN, Moldofsky H.

Clin J Pain. 2009 Jun;25(5):365-75. doi: 10.1097/AJP.0b013e31819be587.

PMID:
19454869
[PubMed - indexed for MEDLINE]
3.

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.

Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM.

Pain. 2008 Jun;136(3):432-44. doi: 10.1016/j.pain.2008.02.024. Epub 2008 Apr 18.

PMID:
18395345
[PubMed - indexed for MEDLINE]
4.

Work disability and health system utilization in patients with fibromyalgia syndrome.

Al-Allaf AW.

J Clin Rheumatol. 2007 Aug;13(4):199-201.

PMID:
17762453
[PubMed - indexed for MEDLINE]
5.

Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians.

Koponen H, Allgulander C, Erickson J, Dunayevich E, Pritchett Y, Detke MJ, Ball SG, Russell JM.

Prim Care Companion J Clin Psychiatry. 2007;9(2):100-7.

PMID:
17607331
[PubMed]
Free PMC Article
6.

Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition.

Nielsen LA, Henriksson KG.

Best Pract Res Clin Rheumatol. 2007 Jun;21(3):465-80. Review.

PMID:
17602994
[PubMed - indexed for MEDLINE]
7.

An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies.

Wernicke J, Lledó A, Raskin J, Kajdasz DK, Wang F.

Drug Saf. 2007;30(5):437-55.

PMID:
17472422
[PubMed - indexed for MEDLINE]
8.

Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.

Hartford J, Kornstein S, Liebowitz M, Pigott T, Russell J, Detke M, Walker D, Ball S, Dunayevich E, Dinkel J, Erickson J.

Int Clin Psychopharmacol. 2007 May;22(3):167-74.

PMID:
17414743
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.

Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.

Depress Anxiety. 2008;25(3):182-9.

PMID:
17311303
[PubMed - indexed for MEDLINE]
10.

A retrospective pooled analysis of duloxetine safety in 23,983 subjects.

Gahimer J, Wernicke J, Yalcin I, Ossanna MJ, Wulster-Radcliffe M, Viktrup L.

Curr Med Res Opin. 2007 Jan;23(1):175-84.

PMID:
17257478
[PubMed - indexed for MEDLINE]
11.

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J.

Neurology. 2006 Oct 24;67(8):1411-20.

PMID:
17060567
[PubMed - indexed for MEDLINE]
12.

Duloxetine in the treatment of major depressive disorder: comparisons of safety and efficacy in U.S. Hispanic and majority Caucasian patients.

Lewis-Fernández R, Blanco C, Mallinckrodt CH, Wohlreich MM, Watkin JG, Plewes JM.

J Clin Psychiatry. 2006 Sep;67(9):1379-90.

PMID:
17017824
[PubMed - indexed for MEDLINE]
13.

Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.

Stewart DE, Wohlreich MM, Mallinckrodt CH, Watkin JG, Kornstein SG.

J Affect Disord. 2006 Aug;94(1-3):183-9. Epub 2006 Jun 14.

PMID:
16780958
[PubMed - indexed for MEDLINE]
14.

The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes.

Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH, Lyon JL.

J Clin Rheumatol. 2006 Jun;12(3):124-8.

PMID:
16755239
[PubMed - indexed for MEDLINE]
15.

The epidemiology of self-reported fibromyalgia in Canada.

McNally JD, Matheson DA, Bakowsky VS.

Chronic Dis Can. 2006;27(1):9-16.

PMID:
16672135
[PubMed - indexed for MEDLINE]
16.

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF.

Pain. 2005 Dec 15;119(1-3):5-15. Epub 2005 Nov 17.

PMID:
16298061
[PubMed - indexed for MEDLINE]
17.

Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.

Mallinckrodt CH, Prakash A, Andorn AC, Watkin JG, Wohlreich MM.

J Psychiatr Res. 2006 Jun;40(4):337-48. Epub 2005 Nov 4.

PMID:
16271726
[PubMed - indexed for MEDLINE]
18.

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.

Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF.

Pain Med. 2005 Sep-Oct;6(5):346-56.

PMID:
16266355
[PubMed - indexed for MEDLINE]
19.

Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.

Vis PM, van Baardewijk M, Einarson TR.

Ann Pharmacother. 2005 Nov;39(11):1798-807. Epub 2005 Sep 27.

PMID:
16189284
[PubMed - indexed for MEDLINE]
20.

Duloxetine vs. placebo in patients with painful diabetic neuropathy.

Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S.

Pain. 2005 Jul;116(1-2):109-18.

PMID:
15927394
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk